Skip to main content
. 2022 Apr 28;13:865643. doi: 10.3389/fimmu.2022.865643

Figure 5.

Figure 5

Forest plots of the association between systemic immune-inflammation index and clinicopathological features in bladder cancer: (A) age (old vs. young); (B) sex (male vs. female); (C) concomitant carcinoma in situ (yes vs. no); (D) lymph node involvement (yes vs. no); (E) lymphovascular invasion (yes vs. no); (F) tumor size (≥3 cm vs. <3 cm); (G) tumor number (unifocal vs. multifocal); (H) tumor differentiation (poor vs. well); (I) tumor stage [muscle-invasive bladder cancer (MIBC): ≥T3 vs. <T3; (J) tumor stage non-muscle-invasive bladder cancer (NMIBC): T1 vs. Tis-Ta].